Pharmaniaga’s growth plans


The group’s focus in the near term would be South-East Asia, says Zulkarnain.

THINGS are looking up for Pharmaniaga Bhd, at least for the next five to 10 years. The homegrown pharmaceutical company has ambitious plans not only to strengthen its foothold in existing markets but also to foray into new international markets.

For the last two decades, the group had established a strong market presence in Indonesia for drug manufacturing and logistics and distribution (L&D). Now, Pharmaniaga has set its sights on markets like the Middle East, Africa and the United States.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Nestle invites Malaysian women to participate in MAGGI entrepreneurship programme
When cheap homes cost more
One property, 10 listings
Rental scams running rampant
China to crack down on 'illegal' cross-border securities
BANK’S PICKLEBALL CHAMPIONSHIP PROMISES WHOLESOME EXPERIENCE
MFM: Balancing growth and returns
Grad squeeze hurts economy
Tapping China’s niche consumer trend
Bubble fears as valuations stretch

Others Also Read